NCT06488482
- Conditions
- High-Risk Melanoma
- Locations
-
- Helsinki University Hospital Helsinki, Finland
- Kuopio University Hospital Kuopio, Finland
- Tampere University Hospital Tampere, Finland
- Turku University Hospital Turku, Finland
Clinical trial condition
High-Risk Melanoma
Explore clinical trials studying High-Risk Melanoma. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
High-Risk Melanoma trial results
Completed
Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk Melanoma
NCT00273910
- Conditions
- High-Risk Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States